Niagen Bioscience, Inc. (NAGE) stock
NAGENasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3011% below fair value
$2.04+0.03 (+1.49%)
Close on Nov 17, 2026Market cap $161.42MP/E 17.0Yield –
Niagen Bioscience profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Niagen Bioscience's profit margin for the twelve months ending Sep 30, 2026 was 8.4%. For fiscal 2025 it was 13.4%, against 8.6% the year before. The highest annual figure on record is 13.4% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13.4% | +4.8 |
| FY2024 | Dec 31, 2024 | 8.6% | +14.5 |
| FY2023 | Dec 31, 2023 | -5.9% | +17.0 |
| FY2022 | Dec 31, 2022 | -23.0% | +17.3 |
| FY2021 | Dec 31, 2021 | -40.2% | −6.6 |
| FY2020 | Dec 31, 2020 | -33.6% | +35.8 |
| FY2019 | Dec 31, 2019 | -69.4% | +36.1 |
| FY2018 | Dec 31, 2018 | -105.6% | −51.9 |
| FY2017 | Dec 30, 2017 | -53.7% | −40.2 |
| FY2016 | Dec 31, 2016 | -13.5% | +2.0 |
| FY2015 | Jan 2, 2016 | -15.5% | +19.7 |
| FY2014 | Jan 3, 2015 | -35.2% | +8.3 |
| FY2013 | Dec 28, 2013 | -43.5% | +57.0 |
| FY2012 | Dec 29, 2012 | -100.4% | −3.1 |
| FY2011 | Dec 31, 2011 | -97.3% | −70.2 |
| FY2010 | Jan 1, 2011 | -27.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -4.3% | −17.8 |
| Q2 FY2026 | Jun 30, 2026 | 3.2% | −8.4 |
| Q1 FY2026 | Mar 31, 2026 | 20.1% | +3.5 |
| Q4 FY2025 | Dec 31, 2025 | 12.2% | −12.4 |
| Q3 FY2025 | Sep 30, 2025 | 13.5% | +6.1 |
| Q2 FY2025 | Jun 30, 2025 | 11.6% | +11.7 |
| Q1 FY2025 | Mar 31, 2025 | 16.6% | +18.8 |
| Q4 FY2024 | Dec 31, 2024 | 24.6% | +24.1 |
| Q3 FY2024 | Sep 30, 2024 | 7.3% | +12.3 |
| Q2 FY2024 | Jun 30, 2024 | -0.1% | +10.7 |
| Q1 FY2024 | Mar 31, 2024 | -2.2% | +6.2 |
| Q4 FY2023 | Dec 31, 2023 | 0.5% | +7.3 |
| Q3 FY2023 | Sep 30, 2023 | -4.9% | +0.9 |
| Q2 FY2023 | Jun 30, 2023 | -10.8% | +27.5 |
| Q1 FY2023 | Mar 31, 2023 | -8.4% | +36.4 |
| Q4 FY2022 | Dec 31, 2022 | -6.8% | +23.2 |
| Q3 FY2022 | Sep 30, 2022 | -5.8% | +45.4 |
| Q2 FY2022 | Jun 30, 2022 | -38.2% | −6.8 |
| Q1 FY2022 | Mar 31, 2022 | -44.8% | +5.4 |
| Q4 FY2021 | Dec 31, 2021 | -30.0% | +9.5 |
| Q3 FY2021 | Sep 30, 2021 | -51.2% | −21.4 |
| Q2 FY2021 | Jun 30, 2021 | -31.4% | −7.2 |
| Q1 FY2021 | Mar 31, 2021 | -50.3% | −9.1 |
| Q4 FY2020 | Dec 31, 2020 | -39.5% | +28.2 |
| Q3 FY2020 | Sep 30, 2020 | -29.7% | +30.0 |
| Q2 FY2020 | Jun 30, 2020 | -24.3% | +45.6 |
| Q1 FY2020 | Mar 31, 2020 | -41.1% | +41.8 |
| Q4 FY2019 | Dec 31, 2019 | -67.6% | +23.0 |
| Q3 FY2019 | Sep 30, 2019 | -59.8% | +46.2 |
| Q2 FY2019 | Jun 30, 2019 | -69.9% | +33.3 |
| Q1 FY2019 | Mar 31, 2019 | -83.0% | +45.6 |
| Q4 FY2018 | Dec 31, 2018 | -90.6% | +26.5 |
| Q3 FY2018 | Sep 30, 2018 | -106.0% | −141.1 |
| Q2 FY2018 | Jun 30, 2018 | -103.2% | −55.0 |
| Q1 FY2018 | Mar 31, 2018 | -128.6% | −104.3 |
| Q4 FY2017 | Dec 30, 2017 | -117.1% | – |
| Q3 FY2017 | Sep 30, 2017 | 35.1% | – |
| Q4 FY2016 | Dec 31, 2016 | -48.2% | – |
| Q3 FY2016 | Oct 1, 2016 | -24.2% | – |
See a number that looks wrong?